Organization
Hirva Mamdani
1 clinical trial
Clinical trial
A Phase II Trial of MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer (MOZART)Status: Recruiting, Estimated PCD: 2024-06-30